Effect of enzyme replacement therapy on the growth of patients with Morquio A.
Caitlin Doherty, Molly Stapleton, Matthew Piechnik...
https://pubmed.ncbi.nlm.nih.gov/31019230/Actively Recruiting
Led by Nemours Children's Clinic · Updated on 2026-05-13
60
Participants Needed
1
Research Sites
N/A
Total Duration
Morquio A disease, also known as Mucopolysaccharidosis IVA MPS IVA, is a rare genetic disorder causing serious skeletal problems and other health issues like joint laxity, tracheal obstruction, and reduced lung capacity. Researchers are working to better understand how the disease progresses and affects patients of all ages. This study aims to develop non-invasive ways to assess these problems and define clear clinical goals for future treatments. The study involves detailed non-invasive assessments including imaging tests like X-rays, MRI, CT angiography, bone density scans, and gait analysis. It also evaluates lung function, joint mobility, hearing, quality of life, and biochemical markers. These tests will be done at different times over several years to track changes and disease progression without burdening patients. Participants will undergo multiple evaluations at baseline and follow-ups at 18, 36, and 48 months. These include physical measurements, questionnaires, pulmonary tests, imaging scans, and hearing and gait analysis. The study carefully tracks many health aspects to better understand the diseases impact and support the design of future clinical trials and therapies for Morquio A patients.
CONDITIONS
Non-invasive Functional Assessment and Pathogenesis of Morquio A
S
Shunji Tomatsu, MD PhD
G
Greg Stets
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nemours Children's Clinic
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 48 months
Participants undergo multiple non-invasive assessments to evaluate various functions including pulmonary, skeletal, gait, joint mobility, hearing, and biochemical analyses.
Visits at baseline, 18 months, 36 months, and 48 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Caitlin Doherty, Molly Stapleton, Matthew Piechnik...
https://pubmed.ncbi.nlm.nih.gov/31019230/Christian Pizarro, Ryan R Davies, Mary Theroux...
https://pubmed.ncbi.nlm.nih.gov/27645974/Wagner A R Baratela, Michael B Bober, Mihir M Thacker...
https://pubmed.ncbi.nlm.nih.gov/24096444/Michael P Whyte, Kenji P Fujita, Scott Moseley...
https://pubmed.ncbi.nlm.nih.gov/29297597/Shunji Tomatsu, Kazuo Okamura, Takeshi Taketani...
https://pubmed.ncbi.nlm.nih.gov/14711889/Adriana M Montaño, Shunji Tomatsu, Ana Brusius...
https://pubmed.ncbi.nlm.nih.gov/18412124/Prakash Sitoula, William G Mackenzie, Suken A Shah...
https://pubmed.ncbi.nlm.nih.gov/24825152/Shunji Tomatsu, Adriana M Montaño, Toshihiro Oguma...
https://pubmed.ncbi.nlm.nih.gov/20107903/Ozgur Dede, Mihir M Thacker, Kenneth J Rogers...
https://pubmed.ncbi.nlm.nih.gov/23824392/A M Montaño, S Tomatsu, G S Gottesman...
https://pubmed.ncbi.nlm.nih.gov/17347914/Nemours Children's Clinic
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor